How InpharmD Uses Pinecone & RAG to Boost Clinical Query Accuracy by 70%

InpharmD is a digital health platform built around a simple but ambitious premise: healthcare professionals deserve instant, evidence-based answers to complex clinical questions. In a landscape where clinicians are pressed for time and the volume of medical literature is overwhelming, InpharmD set out to bridge the gap between raw research and actionable drug information. In 2021, CTO and Co-founder Tulasee Rao Chintha made a pivotal strategic decision to build InpharmD's AI capabilities on top of vector database technology — a move that would define the company's competitive trajectory in digital healthcare.

The core challenge InpharmD faced was the sheer complexity and scale of medical data. Accurate, real-time clinical information is essential for patient safety, treatment efficacy, and regulatory compliance — yet searching the medical literature is notoriously slow and imprecise. With millions of documents to sift through, unreliable sources, and the constant need for up-to-date information, healthcare professionals were losing valuable time. InpharmD needed a way to make its 30-million-document knowledge base not just searchable, but intelligently queryable at scale and with minimal latency.

To solve this, InpharmD developed Sherlock, an AI assistant that combines large language models, human pharmacy expertise, and retrieval-augmented generation (RAG) to answer clinical drug inquiries. After evaluating multiple vector database options, the team selected Pinecone as its core infrastructure partner. Using Pinecone's open-source RAG framework, Canopy, InpharmD processed its entire library of medical PDFs — extracting text, chunking documents, and embedding them as 1,536-dimensional vectors stored in Pinecone alongside rich metadata. This gave Sherlock a long-term semantic memory capable of understanding the nuanced context of clinical questions, not just keyword matches.

The Sherlock workflow operates in four stages: a clinician submits a question, Sherlock translates it into vector embeddings and runs a similarity search in Pinecone via Canopy, the system refines its response through reinforcement learning and human feedback, and finally the InpharmD pharmacy team reviews the output before delivering it to the clinician. This human-in-the-loop approach, powered by Pinecone's low-latency retrieval across over 2 billion vectors, ensures both speed and clinical reliability.

The results have been transformative. InpharmD realized approximately 80% savings in data storage costs, a 75% reduction in overall response time, and a staggering 95x improvement in first response time. Most critically, query accuracy improved by 70%, giving clinicians far greater confidence in the information they receive. With plans to scale their vector index to approximately 40 billion vectors, InpharmD is positioned to continue expanding its medical knowledge base while maintaining the speed and precision that evidence-based patient care demands.